Japan, Oct. 30 -- REGENERON PHARMACEUTICALS INC,INTELLIA THERAPEUTICS INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR EXPRESSING FACTOR IX.' Other related details are as follows:
Application Number: JP,2024-187346
Category (FI): C12N15/55,C12N15/864,100@Z,C12N15/86@Z,A61K31/7105,A61P43/00,121,A61K48/00,A61P7/04,A61P43/00,105,C12N5/10,C12N15/11@Z,C12N15/09,110,C12N15/12
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Oct. 24, 2024
Publication Date: Feb. 12, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.